FORMULATION DESIGN AND OPTIMIZATION OF FLOATING MATRIX TABLETS OF CIPROFLOXACIN HCL BY USING HPMC AND ETHYL CELLULOSE WITH EXPERIMENTAL DESIGN
Abstract
The oral floating matrix tablets of Ciprofloxacin Hydrochloride were formulated by Experimental design by using HPMC K100M and Ethyl Cellulose as the retardant polymers each with three different levels with an approach to increase gastric residence and thereby improve drug bioavailability. From FTIR results it was confirmed that there is no chemical interaction between the drug with the excipients used in tablet formulations. Also, there was no shift in the endotherm of in the drug- excipients mixtures indicating compatibility of drug with all the excipients. All the tablets were prepared by effervescent approach in which Sodium bicarbonate was added as a gas generating agent. Floating Matrix tablets were prepared by direct compression method and prepared tablets were evaluated for weight variation, percentage friability, hardness and drug content studies. All the formulations showed compliance with pharmacopeia standards (I.P. 1996). Floating lag times of all the formulations were within 1 minute and Total floating time of all the formulations were more than 12 hours. In vitro release studies revealed that the release rate decreased with increase polymer proportion of retarding polymers. The formulation CHE9 sustained release of drug for 12 hours with 21% release of drug after 1 hour and more than 97% at the end of 12 hours. From the Kinetic model it was found that the optimized formulation CHE9 showed linearity in case of Zero order (R2: 0.938) and Higuchi model (R2: 0.954). By fitting data to Korsmeyer-Peppas model and ‘n’ value lying above 0.5 indicating non Fickian release.
Keywords:
Oral floating matrix tablets, Experimental design, HPMC K100M, Ethyl Cellulose, Ciprofloxacin HydrochlorideDOI
https://doi.org/10.25004/IJPSDR.2019.110102References
2. Priyanka V, Reddy PSC, Sowmya C, Singh RK. Review article floating tablet and it’s technology. Int J Pharma Drug Anal 2014; 2(8): 653-657.
3. Kataria S, Middha A, Bhardwaj S, Sandhu P. Floating drug delivery system a review. Int Res J of pharmacy 2011; 2(9): 18-24.
4. Venketasurlu K, Jami KP, Badithala SSK. Floating drug delivery system of ciprofloxacin HCl. Asian J Pharma 2016; 10(4): 271-278.
5. Bhatt P, Lalani R, Vhora I, Patil S, Amrutiya J, Misra A, Mashru R. Liposomes encapsulating native and cyclodextrin enclosed Paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation. International Journal of Pharmaceutics. 2018; 536: 95-107.
6. Yewale C, Baradia D, Patil S, Bhatt P, Amrutiya J, Gandhi R, Kore G. Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells. Journal of Drug Delivery Science and Technology. 2018; 45: 334-345.
7. Patel J, Amrutiya J, Bhatt P, Javia A, Jain M, Misra A. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumor cells. Journal of Microencapsulation. 2018; 35(2): 204-217.
8. Abbas N, Ahsan M, Hussain A, Saeed H, Shah PA, Mohammad S, Arshad MS. Formulation Optimization and In-vitro Evaluation of Oral Floating Captopril Matrix Tablets using Factorial Design. Tropical J Pharma Res. 2015; 14(10): 1737-1748.
9. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eu J Pharma Sci. 2001; 13: 123–133.
10. Varshosaz J, Tavakoli N, Kheirolahi F. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS Pharm Sci Tech. 2006; 7(1): E1-E7.
11. Shoaib MH, Tazeen J, Merchant HA, Yousuf RI. Evaluation of drug release kinetics from Ibuprofen matrix tablets using HPMC. Pak J Pharm Sci 2006; 19(2): 119-124.
12. Devarajan K, Rangasamy M, Selvaraj J and Natesan SK. Development and evaluation of floating tablets of ciprofloxacin HCl. Int. journal of pharm and allied sciences archive. 2012 april-june; 1(1):17-25.
13. Reddy KR, Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of Nicorandil: Formulation and in vitro evaluation. AAPS Pharm Sci Tech. 2003; 4 (4): 1-9.
14. Khemariya P, Jain AK, Bhargava M, Singhai SK, Goswami S, Goswami R. Preparation and in-vitro evaluation of sustained-release matrix tablets of Diltiazem. Int J Adv Pharm Sci. 2010; 1: 267-273.
Published

